Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia

Clinical Trial ID NCT02907437

Rank	Title	Journal	Year	PubWeight™‹?›
1	A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.	J Clin Psychiatry	2009	1.64
2	Functional neuroimaging of minocycline's effect in a patient with schizophrenia.	Prog Neuropsychopharmacol Biol Psychiatry	2010	1.43
3	Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.	Psychiatry Clin Neurosci	2009	1.43
4	Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment.	J Psychopharmacol	2012	1.19
5	Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond.	Pharmacol Ther	2011	1.12
6	Minocycline: therapeutic potential in psychiatry.	CNS Drugs	2012	0.92
7	Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia.	J Neuropsychiatry Clin Neurosci	2013	0.84
8	Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.	Psychiatry Res	2014	0.83
9	Psychopharmacology of the negative symptoms: current status and prospects for progress.	Eur Neuropsychopharmacol	2013	0.80
10	The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.	Trials	2015	0.77